Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: Preliminary therapeutic experience

Journal of Endocrinological Investigation

Volumn 22, Issue 11 SUPPL. 1, 1999, Pages 30-34

  Perros, P ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Metastasis; Radioablation; Recombinant human thyroid stimulating hormone (rhTSH); Therapy; Well differentiated thyroid cancer

Indexed keywords

DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RECOMBINANT PROTEIN; THYROGLOBULIN; THYROTROPIN;

ADENOCARCINOMA; AGED; BLOOD; CASE REPORT; HUMAN; MALE; PATHOLOGY; REVIEW; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; AGED; HUMANS; IODINE RADIOISOTOPES; MALE; RECOMBINANT PROTEINS; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN;

EID: 0033255167     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dow K.H., Ferrell B.R., Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1997, 7: 613.
2. Meier C.A., Braverman L.E., Ebner S.A., Veronikis I., Daniels G.H., Ross D.S., Deraska D.J., Davies T.F., Valentine M., DeGroot L.J., Curran P., McEllin K., Reynolds J., Robbins J., Weintraub B.D. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II Study). J. Clin. Endocrinol. Metab. 1994, 78: 188.
3. Ladenson P.W., Braverman L.E., Mazzaferri E.L., Brucker-Davis F., Cooper D.S., Garber J.R., Wondisford F.E., Davies T.F., DeGroot L.J., Daniels G.H., Ross D.S., Weintraub B.D. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N. Engl. J. Med. 1997, 337: 888.
4. Haugen B.R., Pacini F., Reiners C., Schlumberger M., Ladenson P.W., Sherman S.I., Cooper D.S., Graham K.E., Braverman L.E., Skarulis M.C., Davies T.F., DeGroot L.J., Mazzaferri E.L., Daniels G.H., Ross D.S., Luster M., Samuels M.H., Becker D.V., Maxon H.R. III, Cavalieri R.R., Spencer C.A., McEllin K., Weintraub B.D., Ridgway E.C. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J. Clin. Endocrinol. Metab. (in press).
5. Adler M.L., Macapinlac H.A., Robbins R.J. Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin. Endocrine Practice 1998, 4: 282.
6. Rudavsky A.Z., Freeman L.M. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 1311 and recombinant human thyroid-stimulating hormone [Clinical case seminar]. J. Clin. Endocrinol. Metab. 1997, 82: 11.
7. nd Meeting of the British Thyroid Association, November 25, 1998, London, United Kingdom, p. 6.
8. Chiu A.C., Delpassand E.S., Sherman S.I. Prognosis and treatment of brain metastases in thyroid carcinoma. J. Clin. Endocrinol. Metab. 1997, 82: 3637.
9. Luster M., Reinhardt W., Körber C., Laßmann K., Hänschied H., Michalowski U., Rendl J., Eising E., Mann K., Heiners C. The use of recombinant human TSH in a patient with metastatic follicular carcinoma and secondary hypothyroidism. Eur. J. Endocrinol. (in press).
10. th World Congress of Nuclear Medicine and Biology, Berlin, Germany, September 3, 1998.
11. Reiners C. Personal communication. 21 April 1999.
12. Goldberg L.D., Ditcheck, N.T. Thyroid carcinoma with spinal cord compression. JAMA 1981, 245: 953.
13. Park S.-G., Reynolds J.C., Brucker-Davis F., Whatley M., McEllin K., Maxted D., Robbins J., Weintraub B.D. Iodine kinetics during I-131 scanning in patients with thyroid cancer: comparison of studies with recombinant human TSH (rhTSH) vs hypothyroidism. J. Nucl. Med. 1996, 37: 15.
14. th Annual Meeting of the Endocrine Society, June 24-27, 1998, New Orleans, LA, USA, poster session P3-625.